BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid fragment derived from a gastric protein called BPC
Alpha-glucosidase inhibitors: Alpha-glucosidase inhibitors, including acarbose and voglibose, act in the gut to control blood glucose levels
Predrag Sikiric and his team in the late 1990s, this peptide has demonstrated remarkable tissue-healing properties across hundreds of animal studies and growing anecdotal human reports
Sources FDA Pharmacy Compounding Advisory Committee meeting materials, 2324 July 2026 FiercePharma, PCAC Day 2 vote results Orrick, FDA Peptide Compounding Vote analysis 21 CFR 216.23, evaluation criteria for bulk drug substances World Anti-Doping Agency Prohibited List All products supplied by Pro Peptides Plus are intended for laboratory research use only
Our prior blog GLP-1 Drugs: FDA Sued Over Removing Tirzepatide from the Drug Shortage List discusses the litigation
GST (Glutathione S-transferase) is a 26kDa protein, present in eukaryotes and in prokaryotes, where they catalyze a variety of reactions